638 related articles for article (PubMed ID: 14552700)
1. Efficacy, safety and potential clinical roles of the COX-2-specific inhibitors.
van der Bijl P; van der Bijl P
Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):17-22. PubMed ID: 14552700
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 inhibitors: promise or peril?
Mengle-Gaw LJ; Schwartz BD
Mediators Inflamm; 2002 Oct; 11(5):275-86. PubMed ID: 12467519
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2: a therapeutic target.
Turini ME; DuBois RN
Annu Rev Med; 2002; 53():35-57. PubMed ID: 11818462
[TBL] [Abstract][Full Text] [Related]
4. [Current status of study on selective cyclooxygenase-2 inhibitors and evaluation of its application].
He W; Liu CF; Huang CQ
Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):184-6. PubMed ID: 12390825
[TBL] [Abstract][Full Text] [Related]
5. [Coxibs: cyclooxygenase-2 inhibitors].
Turnheim K
Wien Klin Wochenschr; 2001 Aug; 113(15-16):558-65. PubMed ID: 11571832
[TBL] [Abstract][Full Text] [Related]
6. [The cardiovascular safety of cyclooxygenase-2 (COX-2) inhibitors].
Hasdai D; Gottlieb S; Godbourt U; Hod H; Kaluski E
Harefuah; 2002 Oct; 141(10):922-4. PubMed ID: 12420602
[No Abstract] [Full Text] [Related]
7. Use of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 (COX-2) inhibitors: indications and complications.
Pascucci RA
J Am Osteopath Assoc; 2002 Sep; 102(9):487-9. PubMed ID: 12361181
[TBL] [Abstract][Full Text] [Related]
8. [New NSAIDS: COX-1, COX-2, what about them?].
Peretz A
Rev Med Brux; 1998 Sep; 19(4):A399-402. PubMed ID: 9805982
[TBL] [Abstract][Full Text] [Related]
9. Scientific rationale for specific inhibition of COX-2.
Bolten WW
J Rheumatol Suppl; 1998 May; 51():2-7. PubMed ID: 9596548
[TBL] [Abstract][Full Text] [Related]
10. [Preferential COX-2 inhibition: its clinical relevance for gastrointestinal non-steroidal anti-inflammatory rheumatic drug toxicity].
Dammann HG
Z Gastroenterol; 1999 Jan; 37(1):45-58. PubMed ID: 10091284
[TBL] [Abstract][Full Text] [Related]
11. [Biological functions of cyclooxygenase 2: control of its expression and activity].
Jacquemin C
J Soc Biol; 2000; 194(3-4):189-93. PubMed ID: 11324321
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacology of selective COX-2 inhibitors.
Capone ML; Tacconelli S; Sciulli MG; Patrignani P
Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):49-58. PubMed ID: 14552704
[TBL] [Abstract][Full Text] [Related]
13. [Clinical application of cyclooxygenase-2 inhibitors].
Dzielska-Olczak M; Olczak S
Pol Merkur Lekarski; 2001 Jun; 10(60):480-2. PubMed ID: 11503270
[TBL] [Abstract][Full Text] [Related]
14. Do non-steroidal anti-inflammatory drugs and COX-2 selective inhibitors have different renal effects?
Giovanni G; Giovanni P
J Nephrol; 2002; 15(5):480-8. PubMed ID: 12455713
[TBL] [Abstract][Full Text] [Related]
15. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part I.
Moyad MA
Semin Urol Oncol; 2001 Nov; 19(4):294-305. PubMed ID: 11769881
[TBL] [Abstract][Full Text] [Related]
16. [Non-steroidal anti-inflammatory drugs and cyclooxygenase-2-specific inhibitors].
Miehle W
Wien Med Wochenschr; 1999; 149(19-20):541-5. PubMed ID: 10637962
[TBL] [Abstract][Full Text] [Related]
17. COX-1 and COX-2 in health and disease.
Adelizzi RA
J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S7-12. PubMed ID: 10643175
[TBL] [Abstract][Full Text] [Related]
18. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
19. Antiinflammatory and analgesic efficacy of COX-2 specific inhibition: from investigational trials to clinical experience.
Bensen WG
J Rheumatol Suppl; 2000 Oct; 60():17-24. PubMed ID: 11032098
[TBL] [Abstract][Full Text] [Related]
20. [Non-steroidal anti-inflammatory drugs and cyclooxygenase-2 selectivity in gastroenterology].
Ledro Cano D; Gómez Rodríguez BJ; Torres Domínguez Y; Hergueta Delgado P; Herrerías Esteban JM; Herrerías Gutiérrez JM
Rev Esp Enferm Dig; 1999 Apr; 91(4):305-9. PubMed ID: 10348929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
